Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.95% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.98% |
| 4 | Financials | 6.14% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
MainStreet Bancshares
MNSB
$179M
| $2.39M | ﹤0.01% |
101,804
+68,344
| +204% | +$1.87M |
|
|
NBP
3202
NovaBridge Biosciences American Depositary Shares
NBP
$213M
| $2.39M | ﹤0.01% |
690,767
+308,125
| +81% | +$1.49M |
|
3203
PUT
Cummins
CMI
$77.8B
| $2.39M | ﹤0.01% |
10,000
-10,800
| -52% | -$2.64M |
|
|
COOP
3204
DELISTED
Mr. Cooper
COOP
| $2.39M | ﹤0.01% |
58,282
-256,061
| -81% | -$11.2M |
|
3205
John Wiley & Sons Class A
WLY
$2.73B
| $2.38M | ﹤0.01% |
61,401
+42,675
| +228% | +$1.82M |
|
3206
Casella Waste Systems
CWST
$5.96B
| $2.38M | ﹤0.01% |
28,788
-162,535
| -85% | -$12.9M |
|
3207
CS Disco
LAW
$282M
| $2.38M | ﹤0.01% |
357,863
+190,045
| +113% | +$1.35M |
|
3208
Mistras Group
MG
$589M
| $2.37M | ﹤0.01% |
350,150
+135,992
| +64% | +$745K |
|
3209
Nathan's Famous
NATH
$403M
| $2.37M | ﹤0.01% |
31,357
+14,145
| +82% | +$1.05M |
|
|
HPP
3210
Hudson Pacific Properties
HPP
$713M
| $2.37M | ﹤0.01% |
50,910
-50,825
| -50% | -$3.26M |
|
3211
PUT
Bruker
BRKR
$8.7B
| $2.37M | ﹤0.01% |
30,000
+25,000
| +500% | +$1.8M |
|
3212
Clearway Energy Class C
CWEN
$6.52B
| $2.36M | ﹤0.01% |
75,327
+28,966
| +62% | +$931K |
|
3213
CALL
AST SpaceMobile
ASTS
$17.4B
| $2.36M | ﹤0.01% |
+464,100
| New | +$2.68M |
|
3214
CALL
Dentsply Sirona
XRAY
$2.22B
| $2.36M | ﹤0.01% |
60,000
-40,000
| -40% | -$1.47M |
|
3215
J&J Snack Foods
JJSF
$1.67B
| $2.35M | ﹤0.01% |
15,872
+7,167
| +82% | +$1.04M |
|
3216
ICL Group
ICL
$7.23B
| $2.35M | ﹤0.01% |
345,849
-1,801,583
| -84% | -$13.3M |
|
3217
iShares MSCI Poland ETF
EPOL
$841M
| $2.35M | ﹤0.01% |
151,778
+41,954
| +38% | +$666K |
|
3218
PUT
Navient
NAVI
$887M
| $2.35M | ﹤0.01% |
146,700
+45,800
| +45% | +$799K |
|
3219
Synaptics
SYNA
$3.72B
| $2.35M | ﹤0.01% |
21,107
-34,138
| -62% | -$3.93M |
|
|
GTHX
3220
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.35M | ﹤0.01% |
875,134
-796,725
| -48% | -$3.83M |
|
3221
Vodafone
VOD
$37.1B
| $2.34M | ﹤0.01% |
212,238
-341,725
| -62% | -$3.89M |
|
3222
CALL
Dycom Industries
DY
$8.88B
| $2.34M | ﹤0.01% |
+25,000
| New | +$2.32M |
|
3223
Center Bancorp
CNOB
$1.6B
| $2.34M | ﹤0.01% |
132,371
-449,537
| -77% | -$10.2M |
|
3224
CALL
Deutsche Bank
DB
$75.8B
| $2.34M | ﹤0.01% |
250,000
+175,000
| +233% | +$2.09M |
|
3225
PUT
Enphase Energy
ENPH
$4.92B
| $2.33M | ﹤0.01% |
11,100
-25,800
| -70% | -$5.59M |
|
Similar funds
Israel Englander's Q1 2023 Portfolio in Review
As of Q1 2023, Israel Englander held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Israel Englander withdrew a net $7.42B in Q1 2023, closing 1,206 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Israel Englander opened a new position in Warner Bros worth $96.9M.
- Israel Englander's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Israel Englander added most to Linde in Q1 2023, an estimated $374M increase.
- Israel Englander's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Israel Englander fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Israel Englander's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Israel Englander opened 987 new positions and closed 1,206 in Q1 2023.
- Israel Englander's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.